drugset / Trial / NCT01241734

Study of Lenalidomide in Combination With RICE With Lenalidomide Maintenance Post-Auto Transplant for DLBCL

NCT01241734 ↗

NaSingle-groupOpen-labelTreatment

Summary

The standard of care therapy for DLBCL in the relapsed setting is RICE with the plan for the patient to proceed to transplant. This protocol will add Revlimid to the first 7 days of the RICE therapy and again after transplant as maintenance. To improve over all outcome and survival. Hypothesis is that combining lenalidomide with standard of care (RICE) may increase overall response rate thus increasing the number of patients able to proceed with autologous stem cell transplant. This in turn may translate into improved overall survival and progression free survival.

Timeline

Start
2010-10
Primary completion
2014-12
Completion
2015-09-22

Drugs

EvaluationDrugModalityDoseRoute
Subject Lenalidomide Other / unclassified 10 mg —
Subject Lenalidomide Other / unclassified 15 mg —
Subject Lenalidomide Other / unclassified 20 mg —
Subject Lenalidomide Other / unclassified 25 mg —